Wasteosomes (corpora amylacea) as a hallmark of chronic glymphatic insufficiency

dc.contributor.authorRiba Baqués, Marta
dc.contributor.authorValle i Macià, Jaume del
dc.contributor.authorMolina Porcel, Laura
dc.contributor.authorPelegrí i Gabaldà, Carme
dc.contributor.authorVilaplana i Hortensi, Jordi
dc.date.accessioned2023-01-26T08:06:20Z
dc.date.available2023-01-26T08:06:20Z
dc.date.issued2022-11-21
dc.date.updated2023-01-26T08:06:20Z
dc.description.abstractIn different organs and tissues, the lymphatic system serves as a drainage system for interstitial fluid and is useful for removing substances that would otherwise accumulate in the interstitium. In the brain, which lacks lymphatic circulation, the drainage and cleaning function is performed by the glymphatic system, called so for its dependence on glial cells and its similar function to that of the lymphatic system. In the present article, we define glymphatic insufficiency as the inability of the glymphatic system to properly perform the brain cleaning function. Furthermore, we propose that corpora amylacea or wasteosomes, which are protective structures that act as waste containers and accumulate waste products, are, in fact, a manifestation of chronic glymphatic insufficiency. Assuming this premise, we provide an explanation that coherently links the formation, distribution, structure, and function of these bodies in the human brain. Moreover, we open up new perspectives in the study of the glymphatic system since wasteosomes can provide information about which variables have the greatest impact on the glymphatic system and which diseases occur with chronic glymphatic insufficiency. For example, based on the presence of wasteosomes, it seems that aging, sleep disorders, and cerebrovascular pathologies have the highest impact on the glymphatic system, whereas neurodegenerative diseases have a more limited impact. Furthermore, as glymphatic insufficiency is a risk factor for neurodegenerative diseases, information provided by wasteosomes could help to define the strategies and actions that can prevent glymphatic disruptions, thus limiting the risk of developing neurodegenerative diseases.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec727129
dc.identifier.issn0027-8424
dc.identifier.urihttps://hdl.handle.net/2445/192640
dc.language.isoeng
dc.publisherNational Academy of Sciences
dc.relation.isformatofVersió postprint del document publicat a: https://www.pnas.org/doi/10.1073/pnas.2211326119; https://www.pnas.org/doi/10.1073/pnas.2211326119
dc.relation.ispartofProceedings of the National Academy of Sciences of the United States of America - PNAS, 2022, vol. 119, num. 48, p. e2211326119
dc.rights(c) Riba Baques, Marta et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Bioquímica i Fisiologia)
dc.subject.classificationEnvelliment cerebral
dc.subject.classificationMalalties neurodegeneratives
dc.subject.classificationImmunitat
dc.subject.otherAging brain
dc.subject.otherNeurodegenerative Diseases
dc.subject.otherImmunity
dc.titleWasteosomes (corpora amylacea) as a hallmark of chronic glymphatic insufficiency
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
727129.pdf
Mida:
3.69 MB
Format:
Adobe Portable Document Format